Marinos C Dalakas

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Venues

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Therapeutic advances in neurological disorders

Nature reviews. Neurology

Dysphagia

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Aug 1o 2007

United States

Professor :: Neurology

Publications

Marinos C Dalakas
Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies. Therapeutic advances in neurological disorders 16 (2023)
Felix Kohle, Marinos C Dalakas, Helmar Christoph Lehmann
Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy? Therapeutic advances in neurological disorders 16 (2023)
Nicholas H Chia, Andrew McKeon, Marinos C Dalakas, Eoin P Flanagan, James H Bower, Bryan T Klassen, Divyanshu Dubey, Nicholas L Zalewski, Dustin Duffy, Sean J Pittock, Anastasia Zekeridou
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. Annals of clinical and translational neurology (2023)
Felix Kohle, Marinos C Dalakas, Helmar Christoph Lehmann
Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy? Therapeutic advances in neurological disorders 16 (2023)
Marinos C Dalakas
Advances in the therapeutic algorithm for myasthenia gravis. Nature reviews. Neurology (2023)
Marinos C Dalakas, Heinz Wiendl
Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Panos Stathopoulos, Marinos C Dalakas
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Luis A Querol, Hans-Peter Hartung, Richard A Lewis, Pieter A van Doorn, Timothy R Hammond, Nazem Atassi, Miguel Alonso-Alonso, Marinos C Dalakas
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Marinos C Dalakas
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Marinos C Dalakas
Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Marinos C Dalakas
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2021)
Panos Stathopoulos, Marinos C Dalakas
Autoimmune Neurogenic Dysphagia. Dysphagia (2021)
Marinos C Dalakas, Peter J Spaeth
The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors. Therapeutic advances in neurological disorders 14 (2021)
Popianna Tsiortou, Harry Alexopoulos, Marinos C Dalakas
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions. Therapeutic advances in neurological disorders 14 (2021)
Marinos C Dalakas, Harry Alexopoulos, Peter J Spaeth
Complement in neurological disorders and emerging complement-targeted therapeutics. Nature reviews. Neurology 16 (11) (2020)
Akash Virupakshaiah, Marinos C Dalakas, Neeja Desai, Scott Mintzer, Jeffrey B Ratliff
LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection. Neurology(R) neuroimmunology & neuroinflammation 8 (1) (2020)

Marinos C Dalakas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marinos C Dalakas